title: Why are there deadly drugs?
abstract: Some drugs eventually have to be removed from the market because of a negative benefit-to-harm ratio, including an excess of mortality. Drug safety is the result of multiple factors, commencing with how clinical trials are designed, the information generated by and/or hidden through these trials, trial analysis by drug regulatory authorities (DRAs) and the amount of information that DRAs choose to release, the amount of published information regarding drug safety, the effectiveness of postmarket surveillance systems in recognizing and reporting adverse drug reactions, and the structure of DRAs such as the United States Food and Drug Administration and its equivalent in other countries. This commentary will look at each of these issues in order to highlight the problems in the current approach to drug safety and finally indicate how some of these deficiencies should be addressed.
authors: School of Health Policy and Management, York University, 4700 Keele St,, Toronto M3J 1P3, Ontario, Canada. jlexchin@yorku.ca.
authors: Joel
authors: J
authors: Lexchin
mesh_terms: D006801:Humans
references: Arch Intern Med. 2009 Oct 26;169(19):1756-61
references: 19858432
references: Arch Intern Med. 2009 Nov 23;169(21):1985-7
references: 19933960
references: J Urol. 2010 May;183(5):1693-7
references: 20299044
references: BMJ. 2011;342:d2291
references: 21613341
references: Lancet. 2012 May 19;379(9829):1878
references: 22608337
references: Drug Saf. 2004;27(7):477-87
references: 15141997
references: JAMA. 1999 May 12;281(18):1728-34
references: 10328074
references: Lancet. 2005 Oct 8;366(9493):1261-2; discussion 1262
references: 16214589
references: Drug Saf. 2006;29(5):385-96
references: 16689555
references: Arch Intern Med. 2007 Sep 10;167(16):1752-9
references: 17846394
references: N Engl J Med. 2008 Mar 27;358(13):1354-61
references: 18367738
references: JAMA. 2008 Apr 16;299(15):1813-7
references: 18413875
references: Arch Intern Med. 2012 Nov 26;172(21):1680-1
references: 23044937
references: PLoS One. 2014;9(3):e92038
references: 24651766
references: BMC Med. 2015;13:26
references: 25651859